Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...
3d
Zacks.com on MSNCencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against other ...
Cencora has gained 16.4% since the start of the ... One industry peer that looks good is Pediatrix Medical Group, Inc. (MD). MD has a Zacks Rank of # 1 (Strong Buy) and a Value Score of A, a ...
With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions provider specializing in pharmaceutical distribution and related services.
We recently published a list of Top 10 Stocks Analysts are Watching as AI Selloff Deepens. In this article, we are going to ...
In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against other stocks with at least $30 million in insider sales recently. Last week, stocks declined in part ...
3d
Zacks.com on MSNHere's Why You Should Add Cencora Stock to Your Portfolio NowCOR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
In a recent 8-K filing with the Securities and Exchange Commission, Cencora, Inc., a Delaware-based company in the wholesale drug industry and a prominent player in Healthcare Providers & Services ...
Equities research analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Cencora in a note ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results